Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-08-09 | Xeris Biopharma Holdings, Inc. | Schmid John P.
(Director) |
P | Common Stock | A | 4285 | $2.37 - $2.37 | $10,134 |
2022-01-29 | Xeris Biopharma Holdings, Inc. | Hecht Beth
(See Remarks) |
F | Common Stock | D | 178006 | $1.12 - $2.66 | $350,648 |
2022-01-29 | Xeris Biopharma Holdings, Inc. | JOHNSON KENNETH E...
(See Remarks) |
F | Common Stock | D | 74904 | $1.12 - $2.66 | $146,261 |
2022-01-29 | Xeris Biopharma Holdings, Inc. | Pieper Steven
(See Remarks) |
F | Common Stock | D | 204575 | $1.12 - $2.66 | $454,279 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | SHERMAN JEFFREY W
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | BORMANN-KENNEDY B...
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | JOHNSON JOHN
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | PERSKY MARLA
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | Kong Garheng
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
2024-06-05 | Xeris Biopharma Holdings, Inc. | HALKUFF DAWN
(Director) |
A | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |